Jump to content
RemedySpot.com

PSA measurements in expectant management for prostate cancer

Rate this topic


Guest guest

Recommended Posts

Measurements of DNA content and proPSA levels at diagnosis are able to

predict unfavorable biopsy conversion-free survival and may be useful

to stratify an EM cohort that meets the Epstein criteria for T1c

disease....Click on the below link for the full story:<http://www.urotoday.com/3341/browse_categories/beyond_the_abstract/beyond_the_abstract__proprostatespecific_antigen_measurements_in_serum_and_tissue_are_associated_with_treatment_necessity_among_men_enrolled_in_expectant_management_for_prostate_cancer_by_robert_w_veltri_phd0224>Non-doctors are welcome to browse UroToday.com but you'll be requested to register, which you can safely do, since this professional medical site never sends spam!

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...